Peptides for Great Dane hip dysplasia
The short answer
Great Danes carry an elevated predisposition to hip dysplasia. The compounds investigated for it are BPC-157, TB-500, GHK-Cu. At a typical Great Dane weight of 50–80 kg (110–176 lb), this breed falls in the large / giant breed dosing class.
Hip dysplasia in Great Danes
Hip dysplasia is a developmental condition in which the femoral head and acetabulum do not fit together correctly. The resulting laxity grinds cartilage away over years, and the arthritis that follows is what most owners actually notice: difficulty rising, reluctance on stairs, a bunny-hopping gait, and loss of muscle over the hindquarters. Peptide research in this area is directed at the secondary consequences rather than the underlying joint geometry — no compound reshapes a hip. What the literature investigates is whether soft tissue repair and inflammatory modulation can slow cartilage degradation and improve comfort and mobility alongside conventional management.
Dosing at Great Dane body weight
Calculated for a 65 kg (143 lb) dog — the midpoint of the typical range for this breed.
| Compound | Dose at 65 kg | Frequency | Evidence |
|---|---|---|---|
| BPC-157 | 130–650 mcg | Once daily | Emerging evidence |
| TB-500 | 6.5–16.3 mg | Loading 1-2x weekly, then half dose weekly | Emerging evidence |
| GHK-Cu | 1.5-2 mg per day injectable, or topical twice daily | Daily (injectable) / twice daily (topical) | Emerging evidence |
Weigh your dog rather than using a breed average — an individual Great Dane can sit well outside the typical range. Use the dose calculator for an exact figure.
Common questions
What peptides are used for hip dysplasia in Great Danes?+
BPC-157, TB-500, GHK-Cu are investigated for hip dysplasia. No breed-specific pharmacological restriction is established for Great Danes among these compounds.
How much should a Great Dane be given?+
Great Danes typically weigh 50–80 kg (110–176 lb), placing them in the large / giant breed class. BPC-157: approximately 130–650 mcg at 65 kg. TB-500: approximately 6.5–16.3 mg at 65 kg. Weigh your dog rather than relying on a breed average.
Are Great Danes more prone to hip dysplasia?+
Yes. Great Danes carry an elevated predisposition to hip dysplasia. A malformed hip joint that leads to instability, cartilage wear, and secondary arthritis, most common in large and giant breeds.
References
- 1.CANINE STUDYHe L, et al. Pharmacokinetics, distribution, metabolism and excretion of BPC 157 in rats and dogs. Frontiers in Pharmacology, 2022. PMID 36588722
- 2.CANINE STUDYXu C, et al. Preclinical safety evaluation of body protective compound-157. Regulatory Toxicology and Pharmacology, 2020. PMID 32334036
- 3.Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. Orthopaedic Journal of Sports Medicine, 2025. PMC12313605
- 4.Gwyer D, Wragg NM, Wilson SL Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 2019. PMID 30915550
- 5.Jozwiak M, et al. Multifunctionality of BPC 157: Literature and Patent Review. Pharmaceuticals, 2025. PMC11859134
- 6.CANINE STUDYJournal of the American Holistic Veterinary Medical Association Case report: canine stifle injury managed with BPC-157 and TB-500. JAHVM, 2023. View source
- 7.Kleinman HK, Sosne G Thymosin beta 4 promotes dermal healing: animal studies. Annals of the New York Academy of Sciences, 2010. PMID 20536453
- 8.Goldstein AL, Hannappel E, Sosne G, Kleinman HK Thymosin beta-4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 2012. PMID 22074294
- 9.Kwok WH, et al. Doping control analysis of TB-500 in equine urine and plasma. Journal of Chromatography B, 2013. PMID 23084823
- 10.Esposito S, et al. TB500/TB1000: understanding misbranded drugs. Drug Testing and Analysis, 2022. View source
- 11.CANINE STUDYCanapp SO, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery, 2003. PMID 14569578
- 12.Maquart FX, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex in rat experimental wounds. Journal of Clinical Investigation, 1993. PMID 8227350
- 13.Pickart L, Vasquez-Soltero JM, Margolina A GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015. PMC4508379
- 14.Pickart L, Margolina A Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences, 2018. PMC6073405
Other conditions Great Danes are predisposed to: Osteoarthritis.
Where to source research peptides
Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.
Educational information — not veterinary medical advice
Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.